4th Annual Biomanufacturing Asia
-
Upload
rita-parasurum -
Category
Health & Medicine
-
view
123 -
download
5
description
Transcript of 4th Annual Biomanufacturing Asia
Produced by: Associations:
International MarketingPartner:
www.biomanufacturing-asia.com
Increasing Production, Enhancing Quality & Optimizing Operations
Part of
PRODUCTION
BIOPHARMADEVELOPMENT &
WEEK
20 — 23 May 2014Grand Hyatt Shanghai, China
IBC LIFESCIENCES
PLUS:
• WUXI APPTEC • SANOFI • NOVARTIS
• TAKEDA PHARMACEUTICAL • BAXTER
& many more!
BIOBIO4TH ANNUAL
Jingrong Li
Executive Director, Biologics,SIMCERE PHARMACEUTICALS, CHINA
Key Conference Themes:• Regulations, GMP & Standards• Successful Partnerships, Investment
& Financing• Effective Planning, Facility Design &
Development• Improving Operations & Supply Chain
Management• Cost Effective Single-Use Systems &
Technology TransferSteven Lee
Global Head of Biologics Tech Operations &Managing Director,DR. REDDY’S LABORATORIES, SINGAPORE
THE 2014 NEW EXPERT FACULTY INCLUDES:
Ting Xu
Founder & CEO,ALPHAMAB, CHINA Racho Jordanov
President & CEO,JHL BIOTECH, TAIWAN
PRE-CONFERENCE WORKSHOP: 20 MAY 2014Biomanufacturing Technologies & Facility Design
POST-CONFERENCE WORKSHOP: 23 MAY 2014Meeting International Quality & Regulatory
Requirements in Biomanufacturing
Media Partners:
Jeremy Caudill
Global VP Business Development,SAMSUNG BIOLOGICS, KOREA
Darren Ji
Global Head, Asia Emerging Markets Partnering,F. HOFFMANN-LA ROCHE, CHINA
LifeSciences
REGISTER TODAY! +65 6508 2401 / +86 21 2326 3680 [email protected] www.biomanufacturing-asia.com
About the BDP WeekThe Biopharma Development & Production Week isthe leading industry platform for pharma, biotech,CMOs, CROs, research institutes, investors and industrystakeholders to meet, network and discuss currentindustry trends, establish business partnershipsand be updated on investment opportunities inChina and surrounding Asia.
Visit www.biopharmaproduction.com for moreinformation.
Co-Located with:
30+ Top Level SpeakersNew Pre & Post Interactive Workshops4 Interactive Panel DiscussionsHot Topic Round Table DiscussionsMeet the Experts Via Specially Hosted VIP Lunch TablesSpeed Networking SessionsMorning Ice Breaker & Get to Know your PeersConference Cocktail
Acceleron Pharma • AlphaMab • Amgen • Autekbio • Bayer HealthCare • Berna Biotech Korea • Biopharm Services • BioPharmaNeer Alliance • BioprocessingTechnology Institute • Boehringer Ingelheim • Bristol-Myers Squibb • Celltrion Healthcare • Chugai Pharmaceutical • CMC Biologics • CMC Biologics •Compliance Concepts International • Daewoong Pharmaceutical • DMS Biotechnology • Dow Corning • ExcellGene • Genor Biopharma • Genzyme/Sanofi •Indian Immunologicals • Innobiologics • Innovent Biologics • Mass Biologics • Novasep • Pfizer Biotherapeutics • Sartorius Stedim Biotech • Saint Gobain •SFDA Training Center • Shanghai Henlius Biotech • Swiss Federal Institute of Technology • Wuxi Apptec • Yooyoung Pharmaceutical & many more
20 — 23 May 2014Grand Hyatt Shanghai, China
Part ofPRODUCTION
BIOPHARMADEVELOPMENT &
WEEK
Asian countries such as India, Singapore, South Korea& China are fast becoming biomanufacturing hubs.Biologics manufacturing is a huge investment & canamount to US10 million or more to construct, equip, &launch a successful certified GMP plant facility(Biospectrum Asia, 2013). With the intensifying growth& demand of biologics production, IBC’s 4th Annual
Biomanufacturing Conference provides a timelyplatform to explore the opportunities & challengesfaced in this sector including:
The investment opportunities for entering thebiomanufacturing market in China & the surroundingAsian region
Bridging the quality differences of China GMPStandards vs. Europe & the US
What is the growth potential & opportunity fordisposable technologies in biomanufacturing inChina?
Identifying the critical factors in choosing the rightoutsourcing partner
Developing a robust commercial process fortechnology transfer
Examining the impact of the US H.R. 3204 Drug Quality& Security Act in the biomanufacturing industry
For sponsorship opportunities, contact Yvonne Leong atTel: +65 6508 2489
Email: [email protected]
BY INDUSTRY■ Biopharmaceutical / Pharmaceutical /
Biotechnology 45%
■ Technology and Solution Service Providers 20%
■ CMO 15%
■ Research Institutes 10%
■ Government 10%
www.biosimilarasia.com
www.celllineasia.com
LIMITED SPONSORSHIP & EXHIBITION OPPORTUNITIES AVAILABLEDo you provide innovative technology to support the biomanufacturing Industry in Asia?
• Showcase the latest technology• Meet & network with senior decision makers in Asia• Position your brand as the market leader to stand out amidst
competition• Generate new business contacts & strengthen existing accounts
Who Should Attend
SNAPSHOT OF PAST ATTENDING COMPANIES INCLUDE:
Abundant Networking Opportunities &Interactive Formats!
An International EventChina, Taiwan, Hong Kong 55%
Europe 10%
USA 5%Australia 5%Southeast Asia 10%
Japan,Korea 10%
India 5%